Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-liver interface in MRI of liver metastasis enables prediction of EGFR mutation in patients with lung cancer: A proof-of-concept study.

Medical physics - 1 Feb 2024

Hou Shaoping, Wang Hongbo, Wang Xiaoyu, Chen Huanhuan, Zhou Boyu, Meng Ruiqing, Sha Xianzheng, Chang Shijie, Wang Huan, Jiang Wenyan

Abstract excerpt

BACKGROUND: Preoperative prediction of the epidermal growth factor receptor (EGFR) status in non-small-cell lung cancer (NSCLC) patients with liver metastasis (LM) may have potential clinical values for assisting in treatment decision-making. PURPOSE: To explore the value of tumor-liver interface (TLI)-based magnetic resonance imaging (MRI) radiomics for detecting the EGFR mutation in NSCLC patients with LM....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Lung Neoplasms

Share to Magnetic Resonance Imaging

Share to Mutation

Source

Identifiers

PMID: 37408393
DOI: 10.1002/mp.16581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor-liver interface in MRI of liver metastasis enables prediction of EGFR mutation in patients with lung cancer: A proof-of-concept study.PMID 37408393Read ↗

Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC.Semantic proximity Read ↗

Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study.Semantic proximity Read ↗

MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis.Semantic proximity Read ↗

Predicting EGFR mutation status in non-small cell lung cancer patients with brain metastases based on MRI radiomics: A systematic review and meta-analysis.Semantic proximity Read ↗

Prediction of EGFR mutation status in non-small cell lung cancer based on multiparametric MRI radiomics.Semantic proximity Read ↗

Prediction of EGFR Mutation Status in Non-small Cell Lung Cancer Based on Multiparametric MRI RadiomicsSemantic proximity Read ↗

Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.Semantic proximity Read ↗

Contrast-enhanced MRI-based radiomics signatures as new markers for preoperative assessment of the EGFR mutation and subtypes from bone metastasesSemantic proximity Read ↗

A Bayesian meta-analysis on MRI-based radiomics for predicting EGFR mutation in brain metastasis of lung cancer.Semantic proximity Read ↗

Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.Semantic proximity Read ↗

Efficacy and safety of first-line EGFR-TKI combined with chemotherapy versus EGFR-TKI monotherapy in patients with EGFR-mutant non-small cell lung cancer and liver metastases: A propensity score-matched analysis.Semantic proximity Read ↗

Radiomic signatures for the non-invasive prediction of EGFR mutation status in brain metastases of lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.